FLT3

nwamba # Aha ngwaahịa Nkọwa
CPDB0099 Quizartinib; AC-010220; AC-220 Quizartinib bụ onye na-egbochi FMS metụtara tyrosine kinase 3 (FLT3; Kd = 1.6 nM) ma gosipụta oke nhọrọ maka FLT3 mgbe a nwalere ya na panel nke 227 ọzọ kinases. Ọ na-egbochi mmụba nke eriri mkpụrụ ndụ leukemia mmadụ MV4-11, nke na-ebunye ngbanwe nke homozygous FLT3-ITD, yana uru IC50 nke 0.56 nM.1 Na 1 mg / kg / ụbọchị, quizartinib egosila ịgbatị ndụ n'ime òké. ụdị nke FLT3-ITD nnukwu ọrịa leukemia myeloid na ikpochapụ etuto dị na ụdị xenograft òké FLT3 dabere na 10 mg/kg.
nke

Kpọtụrụ anyị

Ajuju

Akụkọ kacha ọhụrụ

  • Usoro 7 kachasị na nyocha ọgwụ na 2018

    Usoro 7 kacha elu na nyocha ọgwụ m...

    N'ịbụ ndị nọ n'okpuru nrụgide na-arịwanye elu mgbe niile ịsọ mpi na gburugburu ebe obibi akụ na ụba na nkà na ụzụ siri ike, ụlọ ọrụ ọgwụ na biotech ga-anọgide na-emepe emepe na mmemme R&D ha iji nọgide na-aga n'ihu ...

  • ARS-1620: Onye mmechi ọhụrụ na-ekwe nkwa maka ọrịa cancer KRAS-mutant

    ARS-1620: ihe mgbochi ọhụrụ na-ekwe nkwa maka K…

    Dị ka otu nnyocha e bipụtara na Cell si kwuo, ndị nchọpụta ewepụtala ihe mgbochi kpọmkwem maka KRASG12C nke a na-akpọ ARS-1602 nke na-eme ka ụbụrụ tumor regression na ụmụ oke. "Ọmụmụ ihe a na-enye na vivo ihe akaebe na mutant KRAS nwere ike ịbụ ...

  • AstraZeneca na-enweta nkwalite nchịkwa maka ọgwụ oncology

    AstraZeneca na-enweta nkwalite nchịkwa maka ...

    AstraZeneca nwetara nkwalite okpukpu abụọ maka pọtụfoliyo oncology ya na Tuesday, mgbe ndị na-ahụ maka US na European nabatara ntinye iwu maka ọgwụ ya, nzọụkwụ mbụ iji nweta nkwado maka ọgwụ ndị a. ...

Mkparịta ụka WhatsApp n'ịntanetị!